The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1

Objectives: Doxorubicin (DOXR) belongs to the antineoplastic anthracycline antibiotic and despite its prevalent use for various types of cancer, it is associated with side effects that occur even after treatment cessation, particularly on the heart, blood, liver and kidney. This study aimed to study...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ahlam M. Alhusaini, Abeer M. Alanazi, Laila M. Fadda, Qamraa H. Alqahtani, Wedad S. Sarawi, Iman H. Hasan
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Hepatotoxicity TGF-β1 SIRT1 Carvedilol Doxorubicin Resveratrol Science (General) Q1-390
Acceso en línea:	https://doaj.org/article/e7b4f8b1900643a0945d6106ac0f70c4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e7b4f8b1900643a0945d6106ac0f70c4
record_format	dspace
spelling	oai:doaj.org-article:e7b4f8b1900643a0945d6106ac0f70c42021-11-18T04:44:17ZThe beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT11018-364710.1016/j.jksus.2021.101640https://doaj.org/article/e7b4f8b1900643a0945d6106ac0f70c42021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1018364721003025https://doaj.org/toc/1018-3647Objectives: Doxorubicin (DOXR) belongs to the antineoplastic anthracycline antibiotic and despite its prevalent use for various types of cancer, it is associated with side effects that occur even after treatment cessation, particularly on the heart, blood, liver and kidney. This study aimed to study the efficiency of carvedilol (CAR), resveratrol (RES) or liposomal RES (LIPO-RES) and their combination to treat DOXR-induced hepatotoxicity and to investigate other driving mechanisms that are involved. Methods: Rats were injected twice weekly with DOXR for five weeks to induce liver injury. A week before DOXR injection commenced, rats were pretreated singly or simultaneously with CAR, RES or LIPO-RES for six weeks. Results: The significant elevation in serum alanine aminotransferase (ALT) and the changed the hepatic tissue structure following DOXR administration indicating hepatic injury. Additionally, DOXR injection caused upregulation of the hepatic malondialdehyde (MDA), inflammatory cytokines, and transforming growth factor-β1 (TGF-β1) levels. The endogenous glutathione (GSH) and sirtuin1 (SIRT1) expressions in the liver were downregulated following DOXR administration. CAR, RES or LIPO-RES as their alternative combinations attenuated the liver injury by controlling oxidative stress, inflammation, and fibrosis. These beneficial effects were apparent upon using combined CAR and LIPO-RES, as proved by restoring the balance of MDA and GSH levels, decreasing hepatic cytokines levels of IL-6 and TNF-α, upregulating SIRT1 and downregulating TGF-β1 levels. Conclusion: The current study indicated that the use of CAR, RES or LIPO-RES alone or in combination could prevent DOXR-induced hepatic damage in rats by inhibiting oxidative stress, inflammation, and fibrosis.Ahlam M. AlhusainiAbeer M. AlanaziLaila M. FaddaQamraa H. AlqahtaniWedad S. SarawiIman H. HasanElsevierarticleHepatotoxicityTGF-β1SIRT1CarvedilolDoxorubicinResveratrolScience (General)Q1-390ENJournal of King Saud University: Science, Vol 33, Iss 8, Pp 101640- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Hepatotoxicity TGF-β1 SIRT1 Carvedilol Doxorubicin Resveratrol Science (General) Q1-390
spellingShingle	Hepatotoxicity TGF-β1 SIRT1 Carvedilol Doxorubicin Resveratrol Science (General) Q1-390 Ahlam M. Alhusaini Abeer M. Alanazi Laila M. Fadda Qamraa H. Alqahtani Wedad S. Sarawi Iman H. Hasan The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
description	Objectives: Doxorubicin (DOXR) belongs to the antineoplastic anthracycline antibiotic and despite its prevalent use for various types of cancer, it is associated with side effects that occur even after treatment cessation, particularly on the heart, blood, liver and kidney. This study aimed to study the efficiency of carvedilol (CAR), resveratrol (RES) or liposomal RES (LIPO-RES) and their combination to treat DOXR-induced hepatotoxicity and to investigate other driving mechanisms that are involved. Methods: Rats were injected twice weekly with DOXR for five weeks to induce liver injury. A week before DOXR injection commenced, rats were pretreated singly or simultaneously with CAR, RES or LIPO-RES for six weeks. Results: The significant elevation in serum alanine aminotransferase (ALT) and the changed the hepatic tissue structure following DOXR administration indicating hepatic injury. Additionally, DOXR injection caused upregulation of the hepatic malondialdehyde (MDA), inflammatory cytokines, and transforming growth factor-β1 (TGF-β1) levels. The endogenous glutathione (GSH) and sirtuin1 (SIRT1) expressions in the liver were downregulated following DOXR administration. CAR, RES or LIPO-RES as their alternative combinations attenuated the liver injury by controlling oxidative stress, inflammation, and fibrosis. These beneficial effects were apparent upon using combined CAR and LIPO-RES, as proved by restoring the balance of MDA and GSH levels, decreasing hepatic cytokines levels of IL-6 and TNF-α, upregulating SIRT1 and downregulating TGF-β1 levels. Conclusion: The current study indicated that the use of CAR, RES or LIPO-RES alone or in combination could prevent DOXR-induced hepatic damage in rats by inhibiting oxidative stress, inflammation, and fibrosis.
format	article
author	Ahlam M. Alhusaini Abeer M. Alanazi Laila M. Fadda Qamraa H. Alqahtani Wedad S. Sarawi Iman H. Hasan
author_facet	Ahlam M. Alhusaini Abeer M. Alanazi Laila M. Fadda Qamraa H. Alqahtani Wedad S. Sarawi Iman H. Hasan
author_sort	Ahlam M. Alhusaini
title	The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
title_short	The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
title_full	The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
title_fullStr	The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
title_full_unstemmed	The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1
title_sort	beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: role of tgf-β1 and sirt1
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/e7b4f8b1900643a0945d6106ac0f70c4
work_keys_str_mv	AT ahlammalhusaini thebeneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT abeermalanazi thebeneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT lailamfadda thebeneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT qamraahalqahtani thebeneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT wedadssarawi thebeneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT imanhhasan thebeneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT ahlammalhusaini beneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT abeermalanazi beneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT lailamfadda beneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT qamraahalqahtani beneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT wedadssarawi beneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1 AT imanhhasan beneficialefficacyofliposomalresveratrolagainstdoxorubicininducedhepatotoxicityinratsroleoftgfb1andsirt1
_version_	1718425134586396672

The beneficial efficacy of liposomal resveratrol against doxorubicin-induced hepatotoxicity in rats: Role of TGF-β1 and SIRT1

Ejemplares similares